Elevated ANGPTL8 levels in steatosis/steatohepatitis have been hypothesized to represent a compensatory mechanism to mitigate hepatic insulin resistance and hyperglycemia, potentially via enhanced β-cell proliferation and insulin secretion (53). The gene discussed is INS; the disease is steatosis.